Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

Michael J. Burke, Archie Bleyer, Kelly W. Maloney et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017

Cited by 46